Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt No Debt
NAS:ALGN's Cash-to-Debt is ranked higher than
99% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. NAS:ALGN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:ALGN' s Cash-to-Debt Range Over the Past 10 Years
Min: 5.57  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.70
NAS:ALGN's Equity-to-Asset is ranked higher than
64% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. NAS:ALGN: 0.70 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:ALGN' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.14  Med: 0.75 Max: 0.89
Current: 0.7
-1.14
0.89
Interest Coverage No Debt
NAS:ALGN's Interest Coverage is ranked higher than
99% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 73.23 vs. NAS:ALGN: No Debt )
Ranked among companies with meaningful Interest Coverage only.
NAS:ALGN' s Interest Coverage Range Over the Past 10 Years
Min: 98.99  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 6
Altman Z-Score: 21.24
Beneish M-Score: -2.33
WACC vs ROIC
11.71%
59.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 22.26
NAS:ALGN's Operating Margin % is ranked higher than
92% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. NAS:ALGN: 22.26 )
Ranked among companies with meaningful Operating Margin % only.
NAS:ALGN' s Operating Margin % Range Over the Past 10 Years
Min: -10.89  Med: 17.06 Max: 26.54
Current: 22.26
-10.89
26.54
Net Margin % 19.18
NAS:ALGN's Net Margin % is ranked higher than
90% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. NAS:ALGN: 19.18 )
Ranked among companies with meaningful Net Margin % only.
NAS:ALGN' s Net Margin % Range Over the Past 10 Years
Min: -10.01  Med: 15.47 Max: 26.31
Current: 19.18
-10.01
26.31
ROE % 23.76
NAS:ALGN's ROE % is ranked higher than
92% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. NAS:ALGN: 23.76 )
Ranked among companies with meaningful ROE % only.
NAS:ALGN' s ROE % Range Over the Past 10 Years
Min: -12.72  Med: 19.29 Max: 42.13
Current: 23.76
-12.72
42.13
ROA % 16.93
NAS:ALGN's ROA % is ranked higher than
94% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.49 vs. NAS:ALGN: 16.93 )
Ranked among companies with meaningful ROA % only.
NAS:ALGN' s ROA % Range Over the Past 10 Years
Min: -9.86  Med: 14.14 Max: 31.86
Current: 16.93
-9.86
31.86
ROC (Joel Greenblatt) % 137.33
NAS:ALGN's ROC (Joel Greenblatt) % is ranked higher than
96% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 6.15 vs. NAS:ALGN: 137.33 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:ALGN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -114.37  Med: 151.29 Max: 369.18
Current: 137.33
-114.37
369.18
3-Year Revenue Growth Rate 18.40
NAS:ALGN's 3-Year Revenue Growth Rate is ranked higher than
83% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. NAS:ALGN: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:ALGN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.6  Med: 15.4 Max: 146.7
Current: 18.4
7.6
146.7
3-Year EBITDA Growth Rate 35.60
NAS:ALGN's 3-Year EBITDA Growth Rate is ranked higher than
84% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 6.30 vs. NAS:ALGN: 35.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NAS:ALGN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -35.3  Med: 25.45 Max: 45.2
Current: 35.6
-35.3
45.2
3-Year EPS without NRI Growth Rate 44.00
NAS:ALGN's 3-Year EPS without NRI Growth Rate is ranked higher than
86% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. NAS:ALGN: 44.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NAS:ALGN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76.1  Med: 20.1 Max: 289.3
Current: 44
-76.1
289.3
GuruFocus has detected 3 Warning Signs with Align Technology Inc $NAS:ALGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:ALGN's 30-Y Financials

Financials (Next Earnings Date: 2017-11-07 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

ALGN Guru Trades in Q3 2016

George Soros 2,515 sh (New)
Steve Mandel 2,436,920 sh (New)
Jim Simons 944,200 sh (+12.51%)
Ruane Cunniff 48,123 sh (unchged)
Ron Baron 26,640 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones 5,700 sh (-0.78%)
Ken Fisher 109,455 sh (-5.86%)
Pioneer Investments 278,266 sh (-12.61%)
Mario Gabelli 4,000 sh (-20.00%)
Mariko Gordon 30,286 sh (-28.60%)
Columbia Wanger 1,614,224 sh (-32.54%)
Steven Cohen 25,300 sh (-50.00%)
Joel Greenblatt 2,504 sh (-83.42%)
» More
Q4 2016

ALGN Guru Trades in Q4 2016

John Hussman 50,000 sh (New)
Jim Simons 1,316,500 sh (+39.43%)
Mariko Gordon 32,066 sh (+5.88%)
Pioneer Investments 285,369 sh (+2.55%)
Steve Mandel 2,476,534 sh (+1.63%)
Ron Baron 26,640 sh (unchged)
George Soros Sold Out
Joel Greenblatt Sold Out
Paul Tudor Jones Sold Out
Ruane Cunniff 48,118 sh (-0.01%)
Ken Fisher 102,242 sh (-6.59%)
Columbia Wanger 1,400,451 sh (-13.24%)
Mario Gabelli 2,500 sh (-37.50%)
Steven Cohen 8,000 sh (-68.38%)
» More
Q1 2017

ALGN Guru Trades in Q1 2017

Jim Simons 1,426,800 sh (+8.38%)
Mariko Gordon 32,066 sh (unchged)
Steve Mandel 2,476,534 sh (unchged)
John Hussman 50,000 sh (unchged)
Steven Cohen Sold Out
Ruane Cunniff 47,593 sh (-1.09%)
Ron Baron 26,040 sh (-2.25%)
Ken Fisher 98,065 sh (-4.09%)
Pioneer Investments 239,434 sh (-16.10%)
Columbia Wanger 1,146,288 sh (-18.15%)
Mario Gabelli 2,000 sh (-20.00%)
» More
Q2 2017

ALGN Guru Trades in Q2 2017

Caxton Associates 2,900 sh (New)
Lee Ainslie 16,140 sh (New)
Ron Baron 106,654 sh (+309.58%)
Jim Simons 1,587,681 sh (+11.28%)
John Hussman Sold Out
Steve Mandel Sold Out
Ken Fisher 96,438 sh (-1.66%)
Pioneer Investments 220,194 sh (-8.04%)
Mario Gabelli 1,800 sh (-10.00%)
Ruane Cunniff 40,144 sh (-15.65%)
Mariko Gordon 23,793 sh (-25.80%)
Columbia Wanger 755,494 sh (-34.09%)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2017-06-30 Add 309.58%0.06%$113.73 - $153.5 $ 186.3238%106,654
Ken Fisher 2017-06-30 Reduce -1.66%$113.73 - $153.5 $ 186.3238%96,438
Ruane Cunniff 2017-06-30 Reduce -15.65%0.01%$113.73 - $153.5 $ 186.3238%40,144
Mariko Gordon 2017-06-30 Reduce -25.80%0.05%$113.73 - $153.5 $ 186.3238%23,793
Mario Gabelli 2017-06-30 Reduce -10.00%$113.73 - $153.5 $ 186.3238%1,800
Steve Mandel 2017-06-30 Sold Out 1.49%$113.73 - $153.5 $ 186.3238%0
Ken Fisher 2017-03-31 Reduce -4.09%$89.98 - $114.71 $ 186.3284%98,065
Ruane Cunniff 2017-03-31 Reduce -1.09%$89.98 - $114.71 $ 186.3284%47,593
Ron Baron 2017-03-31 Reduce -2.25%$89.98 - $114.71 $ 186.3284%26,040
Mario Gabelli 2017-03-31 Reduce -20.00%$89.98 - $114.71 $ 186.3284%2,000
Steve Mandel 2016-12-31 Add 1.63%0.02%$84.14 - $101.14 $ 186.32101%2,476,534
Ken Fisher 2016-12-31 Reduce -6.59%$84.14 - $101.14 $ 186.32101%102,242
Ruane Cunniff 2016-12-31 Reduce -0.01%$84.14 - $101.14 $ 186.32101%48,118
Mariko Gordon 2016-12-31 Add 5.88%0.01%$84.14 - $101.14 $ 186.32101%32,066
Mario Gabelli 2016-12-31 Reduce -37.50%$84.14 - $101.14 $ 186.32101%2,500
Joel Greenblatt 2016-12-31 Sold Out $84.14 - $101.14 $ 186.32101%0
George Soros 2016-12-31 Sold Out 0.01%$84.14 - $101.14 $ 186.32101%0
Steve Mandel 2016-09-30 New Buy1.02%$80.87 - $96.29 $ 186.32106%2,436,920
Ken Fisher 2016-09-30 Reduce -5.86%$80.87 - $96.29 $ 186.32106%109,455
Mariko Gordon 2016-09-30 Reduce -28.60%0.06%$80.87 - $96.29 $ 186.32106%30,286
Mario Gabelli 2016-09-30 Reduce -20.00%$80.87 - $96.29 $ 186.32106%4,000
George Soros 2016-09-30 New Buy0.01%$80.87 - $96.29 $ 186.32106%2,515
Joel Greenblatt 2016-09-30 Reduce -83.42%0.01%$80.87 - $96.29 $ 186.32106%2,504
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:NYSE:TFX, NYSE:VAR, NAS:ABMD, NYSE:ZBH, NYSE:EW, NAS:MASI, NAS:IART, NYSE:PEN, NAS:NUVA, NYSE:GMED, NYSE:NVRO, NAS:INGN, NAS:SPNC, NAS:MDXG, NYSE:ITGR, NAS:CNMD, NAS:BABY, NAS:CSII, NAS:KTWO, NAS:XENT » details
Traded in other countries:AFW.Germany,
Headquarter Location:USA
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage. Its segments are Clear Aligner and Scanners & Services.

Align Technology Inc was incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner and Scanners and Services. The Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanners and Services segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.

Ratios

vs
industry
vs
history
PE Ratio 63.81
ALGN's PE Ratio is ranked lower than
74% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.71 vs. ALGN: 63.81 )
Ranked among companies with meaningful PE Ratio only.
ALGN' s PE Ratio Range Over the Past 10 Years
Min: 5.57  Med: 32.88 Max: 222.88
Current: 63.81
5.57
222.88
Forward PE Ratio 46.08
ALGN's Forward PE Ratio is ranked lower than
82% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 25.64 vs. ALGN: 46.08 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 63.81
ALGN's PE Ratio without NRI is ranked lower than
72% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 31.10 vs. ALGN: 63.81 )
Ranked among companies with meaningful PE Ratio without NRI only.
ALGN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.57  Med: 32.88 Max: 222.88
Current: 63.81
5.57
222.88
Price-to-Owner-Earnings 83.66
ALGN's Price-to-Owner-Earnings is ranked lower than
80% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 36.31 vs. ALGN: 83.66 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ALGN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 32.18 Max: 895
Current: 83.66
5.35
895
PB Ratio 13.85
ALGN's PB Ratio is ranked lower than
92% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. ALGN: 13.85 )
Ranked among companies with meaningful PB Ratio only.
ALGN' s PB Ratio Range Over the Past 10 Years
Min: 1.86  Med: 5.53 Max: 15.87
Current: 13.85
1.86
15.87
PS Ratio 12.26
ALGN's PS Ratio is ranked lower than
84% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. ALGN: 12.26 )
Ranked among companies with meaningful PS Ratio only.
ALGN' s PS Ratio Range Over the Past 10 Years
Min: 1.31  Med: 4.84 Max: 12.42
Current: 12.26
1.31
12.42
Price-to-Free-Cash-Flow 80.24
ALGN's Price-to-Free-Cash-Flow is ranked lower than
84% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.13 vs. ALGN: 80.24 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ALGN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.18  Med: 23.66 Max: 28460
Current: 80.24
11.18
28460
Price-to-Operating-Cash-Flow 50.82
ALGN's Price-to-Operating-Cash-Flow is ranked lower than
86% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 19.50 vs. ALGN: 50.82 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ALGN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.24  Med: 19.92 Max: 351.69
Current: 50.82
8.24
351.69
EV-to-EBIT 51.98
ALGN's EV-to-EBIT is ranked lower than
78% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 24.67 vs. ALGN: 51.98 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -378.4  Med: 22.6 Max: 157.9
Current: 51.98
-378.4
157.9
EV-to-EBITDA 46.75
ALGN's EV-to-EBITDA is ranked lower than
85% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 17.99 vs. ALGN: 46.75 )
Ranked among companies with meaningful EV-to-EBITDA only.
ALGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.4  Med: 19.8 Max: 243.5
Current: 46.75
-248.4
243.5
EV-to-Revenue 11.57
ALGN's EV-to-Revenue is ranked lower than
79% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.70 vs. ALGN: 11.57 )
Ranked among companies with meaningful EV-to-Revenue only.
ALGN' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.9  Med: 4.4 Max: 12
Current: 11.57
0.9
12
PEG Ratio 2.73
ALGN's PEG Ratio is ranked lower than
52% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. ALGN: 2.73 )
Ranked among companies with meaningful PEG Ratio only.
ALGN' s PEG Ratio Range Over the Past 10 Years
Min: 1.22  Med: 1.67 Max: 2.73
Current: 2.73
1.22
2.73
Shiller PE Ratio 145.59
ALGN's Shiller PE Ratio is ranked lower than
89% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 49.44 vs. ALGN: 145.59 )
Ranked among companies with meaningful Shiller PE Ratio only.
ALGN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 73.35  Med: 99.19 Max: 680.5
Current: 145.59
73.35
680.5
Current Ratio 2.36
ALGN's Current Ratio is ranked lower than
51% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. ALGN: 2.36 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 2.95 Max: 6.96
Current: 2.36
1.59
6.96
Quick Ratio 2.28
ALGN's Quick Ratio is ranked higher than
59% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. ALGN: 2.28 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s Quick Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.89 Max: 6.82
Current: 2.28
1.55
6.82
Days Inventory 35.40
ALGN's Days Inventory is ranked higher than
91% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. ALGN: 35.40 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s Days Inventory Range Over the Past 10 Years
Min: 9.28  Med: 24.09 Max: 35.4
Current: 35.4
9.28
35.4
Days Sales Outstanding 85.96
ALGN's Days Sales Outstanding is ranked lower than
65% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. ALGN: 85.96 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.57  Med: 63.3 Max: 85.96
Current: 85.96
57.57
85.96
Days Payable 55.43
ALGN's Days Payable is ranked lower than
57% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 54.45 vs. ALGN: 55.43 )
Ranked among companies with meaningful Days Payable only.
ALGN' s Days Payable Range Over the Past 10 Years
Min: 25.83  Med: 46.94 Max: 68.75
Current: 55.43
25.83
68.75

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.40
ALGN's 3-Year Average Share Buyback Ratio is ranked higher than
88% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. ALGN: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ALGN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -139.2  Med: -3.4 Max: 0.5
Current: 0.4
-139.2
0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 115.72
ALGN's Price-to-Net-Cash is ranked lower than
93% of the 107 Companies
in the Global Medical Devices industry.

( Industry Median: 15.73 vs. ALGN: 115.72 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ALGN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.73  Med: 20.83 Max: 417
Current: 115.72
1.73
417
Price-to-Net-Current-Asset-Value 28.15
ALGN's Price-to-Net-Current-Asset-Value is ranked lower than
84% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 6.83 vs. ALGN: 28.15 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ALGN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.35  Med: 9.28 Max: 28.15
Current: 28.15
1.35
28.15
Price-to-Tangible-Book 15.13
ALGN's Price-to-Tangible-Book is ranked lower than
85% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 3.98 vs. ALGN: 15.13 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ALGN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.91  Med: 6.21 Max: 16.46
Current: 15.13
0.91
16.46
Price-to-Intrinsic-Value-Projected-FCF 4.69
ALGN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
71% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.41 vs. ALGN: 4.69 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ALGN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.38  Med: 2.24 Max: 14.76
Current: 4.69
1.38
14.76
Price-to-Median-PS-Value 2.53
ALGN's Price-to-Median-PS-Value is ranked lower than
91% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. ALGN: 2.53 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ALGN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.37  Med: 0.9 Max: 6.53
Current: 2.53
0.37
6.53
Price-to-Peter-Lynch-Fair-Value 2.56
ALGN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
54% of the 56 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. ALGN: 2.56 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ALGN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.57  Med: 1.94 Max: 14.72
Current: 2.56
0.57
14.72
Price-to-Graham-Number 6.55
ALGN's Price-to-Graham-Number is ranked lower than
83% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. ALGN: 6.55 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ALGN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.85  Med: 3.29 Max: 17.76
Current: 6.55
0.85
17.76
Earnings Yield (Greenblatt) % 1.92
ALGN's Earnings Yield (Greenblatt) % is ranked higher than
58% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. ALGN: 1.92 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ALGN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -6  Med: 3.7 Max: 9.7
Current: 1.92
-6
9.7
Forward Rate of Return (Yacktman) % 35.69
ALGN's Forward Rate of Return (Yacktman) % is ranked higher than
92% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.78 vs. ALGN: 35.69 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ALGN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -2.3  Med: 2.7 Max: 36
Current: 35.69
-2.3
36

More Statistics

Revenue (TTM) (Mil) $1,238.62
EPS (TTM) $ 2.92
Beta1.58
Short Percentage of Float4.84%
52-Week Range $83.27 - 190.04
Shares Outstanding (Mil)80.15

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 1,398 1,656 1,932
EPS ($) 3.41 4.10 4.72
EPS without NRI ($) 3.41 4.10 4.72
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
John Hussman Exits Ebix and Amazon, Sells Mattel Aug 18 2017 
Invisalign® Brand Teams Up With Superstar Athletes Gabrielle Reece, Laird Hamilton, And Their Daugh Jun 21 2017 
Hilton Worldwide, Align Technology, ANSYS Set to Join S&P 500; Teradata and Ryder System to Join S&P Jun 09 2017 
Align Technology Launches Invisalign Brand Marketing Campaign to Challenge Metal Braces as the Statu May 09 2017 
Stocks That Are Beating the Market Apr 12 2017 
6 Stocks That Are Beating the Market Oct 11 2016 
Align Technology to Announce Second Quarter 2016 Results on July 28, 2016 Jul 01 2016 
Align Technology to Speak at Upcoming Financial Conferences Jun 06 2016 
Align Technology Awards Fourteen Grants Totaling $310,000 as Part of Its University Research Award P Jun 01 2016 
Align Technology to Host Analyst Meeting on June 2, 2016 May 16 2016 

More From Other Websites
ETFs with exposure to Align Technology, Inc. : September 19, 2017 Sep 19 2017
The Zacks Analyst Blog Highlights: iShares Core S&P 500 ETF, Vertex Pharmaceuticals, Align... Sep 19 2017
5 Top-Performing Stocks Driving S&P 500 ETF Higher Sep 18 2017
3D Printing Moves Align Technology Toward $1.3 Billion In Sales Sep 14 2017
3 Stocks That Look Just Like Netflix in 2002 Sep 14 2017
3 Stocks to Buy and Forget About Sep 13 2017
Align Technology Introduces a New Brand Identity for the iTero(R) Scanning System and Tools Sep 12 2017
Align Technology, Inc. :ALGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 7, 2017 Sep 07 2017
Align Technology at 52-Week High: What's Driving the Stock? Sep 06 2017
Align Technology, Inc. (ALGN): Up More Than 85% and Still Smiling Sep 01 2017
BioScrip's Infusion Business Strong, Dull 2017 View a Drag (Revised) Sep 01 2017
Align Technology-Patterson Dental Deal Expands iTero Reach Aug 24 2017
Cramer Remix: Amazon is finally facing a real rival Aug 23 2017
Patterson Dental and Align Technology Announce Distribution Agreement for the iTero® Element... Aug 23 2017
Align Technology's Invisalign Sales Strong Amid Margin Woes Aug 22 2017
Cerner (CERN) Banks on RCM & PH Platforms, Competition Rife Aug 22 2017
Quality Systems Professional Service a Drag, Competition Rife Aug 22 2017
Here's Why You Must Add Chemed (CHE) Stock to Your Portfolio Aug 21 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}